ENVISION HLTHCR Stock Analysis, Valuation (NYSE:EVHC)

Add to My Stocks
$37.19 $0.47 (1.25%) EVHC stock closing price Feb 23, 2018 (Closing)
Watch Robo Advisor Video of EVHC Stock Analysis
ENVISION HLTHCR
Updated on : Feb 23, 2018
previous close
EVHC 37.2 (0%)
S&P 500 2747.3 (0%)
Closing Price On: Feb 23, 2018
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Outpatient-Home care
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2017-Q3
$billion
%
YOY GROWTH
Compared to the industry
Operating Profit
Operating Margin:
5.7%
Sector Average:
-5.2%
5 Quarter Net Profit
Net Margins
2017-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
6.32B
Debt/Equity Ratio:
 0.9
Compared to the industry
Cash Flow
Operating cash flow:
$182.3M
Net Income:
$28.3M
PROS      CONS
Recent Growth
Operating Margins
Cash Flow
ROIC
FCF Margin
PE Valuation
Net Margins
High Debt Burden
ROE
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
EVHC PS :
0.6
Industry PS :
6
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
2.4%
Return on Equity:
-7.9%
Free Cash Flow Margin:
6.8%
Double Tap To Exit Full Screen
0:00
/

ENVISION HLTHCR Stock Analysis

137 5 2

View the ENVISION HLTHCR stock analysis video on Amigobulls. Our EVHC analysis video highlights revenue and profit trends along with other important metrics such as valuation to find what makes the stock attractive.

Note: Amigobulls stock rating is our opinion based on the historical performance of the company's fundamentals. It is not indicative of the future performance of the stock.

ENVISION HLTHCR Stock Rating 3.4/5

We at Amigobulls use various financial measures including profit margins, revenue growth and dividends for EVHC stock analysis. ENVISION HLTHCR valuation forms a crucial part of our stock analysis. ENVISION HLTHCR stock rating is our opinion about the business fundamentals of the company.

Should you buy EVHC stock?

  • The Year Over Year (YoY) revenue growth for ENVISION HLTHCR was 142.1% in 2017 Q3.
  • ENVISION HLTHCR had a healthy average operating margin of 5.7% over the last 4 quarters.
  • The operating cash flow looks good at 6.4 times the net income.
  • The price to earnings multiple of 11.5 is attractive when compared with the industry average PE ratio of 23.5.
  • EVHC stock is trading at a favorable price to sales multiple of 0.6 as against the Medical-Outpatient-Home care industry average multiple of 6.
  • ENVISION HLTHCR has an attractive ROIC (Return on Invested Capital) of 2.4%
  • The company has a healthy free cash flow margin of 6.8%.

Should you sell EVHC stock?

  • ENVISION HLTHCR registered an average TTM Net loss of -6.4%.
  • ENVISION HLTHCR has a debt/equity ratio of  0.9, which is worse than the average in the Medical sector.
  • A negative ROE of -7.9% indicates that the company is not able to generate profits with the money shareholders have invested.

Comments on this video and ENVISION HLTHCR stock

Amigobulls ENVISION HLTHCR stock analysis helps investors in understanding how the company's fundamentals have performed in the last few quarters. The fundamentals of a company are vital to identify long-term investment opportunities.

ENVISION HLTHCR revenue growth is an indicator of the demand for a company's products while profit margin is indicative of company's pricing power and pricing strategy. Investors could make use of EVHC technical analysis to check whether the fundamental story is reflected in the market sentiment.